The Global Inhaled Nitric Oxide Delivery Systems Market is Estimated to Grow from USD 247.5 Million in 2020 to USD 434.2 Million by 2027 - ResearchAndMarkets.com
Retrieved on:
Thursday, February 17, 2022
Medical Devices, Health, Diamond, Asthma, Nitric oxide, AHRF, INO, Hypoxic pulmonary vasoconstriction, Incidence, Pulmonary hypertension, HRF, World, Sepsis, Safety, Ino, WHO, Application, Social support, Degenerative disease, USD, Pneumonia, Public health, Disease, World Health Organization, COVID-19, Toxicity, CAGR, Pharmaceutical industry
The "Inhaled Nitric Oxide Delivery Systems Market" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Inhaled Nitric Oxide Delivery Systems Market" report has been added to ResearchAndMarkets.com's offering.
- The global Inhaled Nitric Oxide Delivery Systems market is estimated to grow from USD 247.5 million in 2020 to USD 434.2 million by 2027, at a CAGR of 6.9%.
- Inhaled Nitric Oxide (INO), a minimally invasive therapy, is being investigated for the treatment of diseases linked with reversible pulmonary vasoconstriction and pulmonary hypertension in children and adults.
- The key players profiled in Inhaled Nitric Oxide Delivery Systems market analysis are: